Rate My Professor Sayed Ali

Sayed Ali is a Clinical Senior Lecturer at Curtin University in Western Australia and an experienced medical oncologist. He obtained his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Utkal University in India and holds Fellowship of the Royal Australasian College of Physicians (FRACP). His medical training included postgraduate physician training at the St Vincent network in Sydney, followed by specialist training in medical oncology at Royal Prince Alfred Hospital and Liverpool Hospital. As a clinical trial fellow during an elective year at Sydney’s Westmead Hospital, he coordinated early-phase clinical trials involving novel targeted therapies and immunotherapies for various tumor types. Prior to his current roles, he established melanoma and immunotherapy services at The Canberra Hospital.

A/Prof Ali currently serves as a medical oncologist at Icon Cancer Centre Midland, consulting Tuesdays and Thursdays, as well as at St John of God Midland Hospital and the Midwest Cancer Centre in Geraldton. He is also an Adjunct Associate Professor at the University of Canberra. His clinical practice encompasses a broad spectrum of solid tumor malignancies, with particular expertise in immunotherapy, gastrointestinal cancers, colorectal cancer, lung cancer, melanoma, and prostate cancer. He contributes to the Kirkbride Melanoma Advisory Service and is a member of prominent organizations such as the American Society of Clinical Oncology (ASCO), Medical Oncology Group of Australia (MOGA), Clinical Oncology Society of Australia (COSA), and Australia and New Zealand Melanoma Trials Group (ANZMTG). In academia, A/Prof Ali is committed to teaching and research in cancer immunology and immunotherapy. His translational research, conducted in partnership with the Australian National University Medical School and the University of Canberra, focuses on identifying patients who benefit from immune checkpoint inhibitors and predicting associated toxicities. He has authored publications in high-impact journals including Asia-Pacific Journal of Clinical Oncology, Journal of Clinical Oncology, and Melanoma Research, and has presented findings at national and international conferences.